Cargando…
Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study
The antitumor drug topotecan (TPT) is a potent inhibitor of topoisomerase I, triggering DNA breaks lethal for proliferating cancer cells. The mechanism is common to camptothecins SN38 (the active metabolite of irinotecan) and belotecan (BLT). Recently, TPT was shown to bind the ribosomal protein L15...
Autores principales: | Bailly, Christian, Vergoten, Gérard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967338/ https://www.ncbi.nlm.nih.gov/pubmed/36838813 http://dx.doi.org/10.3390/molecules28041828 |
Ejemplares similares
-
Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues
por: Vergoten, Gérard, et al.
Publicado: (2023) -
Binding of Vialinin A and p-Terphenyl Derivatives to Ubiquitin-Specific Protease 4 (USP4): A Molecular Docking Study
por: Bailly, Christian, et al.
Publicado: (2022) -
Anticancer Properties and Mechanism of Action of Oblongifolin C, Guttiferone K and Related Polyprenylated Acylphloroglucinols
por: Bailly, Christian, et al.
Publicado: (2021) -
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
por: Bailly, Christian, et al.
Publicado: (2020) -
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
por: Thuru, Xavier, et al.
Publicado: (2022)